Ask Us
Register
Monitoring Medicines for over 2,573,000 Members
Australia
Brasil
Deutschland
España
France
United Kingdom
United States
English
Español
What is MediGuard?
Drugs A to Z
Conditions
Research
About Us
Recent Pages:
Epipen satisfaction and usage data | Monitoring more than 1,200 patients | Drug safety information
/
Keppra satisfaction and usage data | Monitoring more than 6,100 patients | Drug safety information
/
Cardec satisfaction and usage data | Monitoring several patients | Drug safety information
Please correct the highlighted fields below.
Alerts for
Varenicline
Title
Date Published
Source
FDA Issues Safety Review Update on Chantix and Mental Health Adverse Effects
2011-10-24
Evaluación De Un Nuevo Estudio Sobre Reacciones Cardiovasculares De Champix
2011-07-26
Chantix: New Study Links Drug to Heart Problems
2011-07-07
FDA Warns: Chantix (varenicline) May Increase the Risk of Heart Attack, Angina and Other Heart-Related Adverse Events in Patients with Cardiovascular Disease
2011-06-16
New Boxed Warning For Chantix (Varenicline)
2009-07-01
FDA reviewing cases of suicidal ideation and occasional suicidal behavior
2007-11-20
See alerts for all drugs